Trials / Completed
CompletedNCT00640458
Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder
A Double Blind, Placebo Controlled 2-way Cross-over Study to Assess the Clitoral Engorgement Response as Measured by Non-contrast Magnetic Resonance Imaging (MRI) in Women With Female Sexual Arousal Disorder (FSAD) When Administered a Single Dose of Sildenafil (100mg) Followed by Audio/Visual Sexual Stimulation
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effect of 100 mg sildenafil on clitoral engorgement in pre-menopausal women, as well as examining the safety and toleration of the drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil 100 mg | |
| DRUG | Placebo |
Timeline
- Start date
- 2004-04-01
- Completion
- 2007-03-01
- First posted
- 2008-03-21
- Last updated
- 2021-02-01
Locations
3 sites across 2 countries: United States, Australia
Source: ClinicalTrials.gov record NCT00640458. Inclusion in this directory is not an endorsement.